Koen Andries
Template:Short description Template:DMCA
Page Module:Infobox/styles.css has no content.
Koen Andries | |
|---|---|
| Born | Script error: No such module "person date". |
| Died | Script error: No such module "person date". |
| Alma mater | University of Ghent |
| OccupationTemplate:Pluralize from text | Janssen Pharmaceutica and professor at the University of Antwerp |
| EmployerTemplate:Pluralize from text | Template:Pluralize from text |
| OrganizationTemplate:Pluralize from text | Template:Pluralize from text |
| AgentTemplate:Pluralize from text | Template:Pluralize from text |
| Notable creditTemplate:Pluralize from text | Template:Pluralize from text |
| LabelTemplate:Pluralize from text | Template:Pluralize from text |
| OpponentTemplate:Pluralize from text | Template:Pluralize from text |
Criminal chargeTemplate:Pluralize from text | Template:Pluralize from text |
| SpouseTemplate:Pluralize from text | Template:Pluralize from text |
| PartnerTemplate:Pluralize from text | Template:Pluralize from text |
| Template:Pluralize from text | |
Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".
Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB).[1]
Career
Andries graduated as a Veterinarian and obtained a PhD at the University of Ghent (Ghent, Belgium) in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in Beerse until 2004. In 2004 he continued his research at Tibotec in Mechelen.[citation needed]
Recognition
- 2014 winner of the European Inventor Award in the Industry category [2] awarded by the European Patent Office.
References
- ^ Andries K, Verhasselt P, Guillemont J, et al. (2005), A diarylquinoline drug active on the ATP-synthase of Mycobacterium tuberculosis, Science 307 (5707): 223–27
- ^ Invention: Drug against multidrug-resistant tuberculosis
External links
Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.
